| Full Name | Ryan J Stolworthy |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine - Emergency Medical Services |
| Location | 1400 N 500 E, Logan, Utah |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417981234 | NPI | - | NPPES |
| D4636 | Medicaid | UT | |
| P00000456 | Other | RAILROAD MEDICARE | |
| 51101391200001 | Other | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207PE0004X | Emergency Medicine - Emergency Medical Services | 5110139 (Utah) | Primary |
| Entity Name | Emergency Physicians Integrated Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578598199 PECOS PAC ID: 4284548116 Enrollment ID: O20031115000013 |
News Archive
A team led by UT Southwestern researchers has identified brain circuitry that plays a key role in the dysfunctional social, repetitive, and inflexible behavioral differences that characterize autism spectrum disorders (ASD).
Trevena Inc., a leader in the discovery of G-protein coupled receptor biased ligands, today announced that its scientists are presenting research data at two scientific conferences. These oral presentations highlight Trevena's research demonstrating that ligand bias at the angiotensin II type I receptor translates into differentiable and beneficial cardiovascular pharmacology in vivo.
The Pancreatic Cancer Action Network and the American Association for Cancer Research have awarded Zeshaan A. Rasheed, M.D., Ph.D., the 2010 Pancreatic Cancer Action Network-AACR Pathway to Leadership Grant.
CyDex Pharmaceuticals, Inc. today announced that its stockholders have voted to approve an Agreement and Plan of Merger between CyDex and Ligand Pharmaceuticals Incorporated and that closing of the transaction has taken place. CyDex will continue its business operations, based in Lenexa, Kansas, as a wholly owned subsidiary of Ligand.
› Verified 7 days ago
| Entity Name | Rocky Mountain Emergency Specialists Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225078736 PECOS PAC ID: 5597662320 Enrollment ID: O20031218000389 |
News Archive
A team led by UT Southwestern researchers has identified brain circuitry that plays a key role in the dysfunctional social, repetitive, and inflexible behavioral differences that characterize autism spectrum disorders (ASD).
Trevena Inc., a leader in the discovery of G-protein coupled receptor biased ligands, today announced that its scientists are presenting research data at two scientific conferences. These oral presentations highlight Trevena's research demonstrating that ligand bias at the angiotensin II type I receptor translates into differentiable and beneficial cardiovascular pharmacology in vivo.
The Pancreatic Cancer Action Network and the American Association for Cancer Research have awarded Zeshaan A. Rasheed, M.D., Ph.D., the 2010 Pancreatic Cancer Action Network-AACR Pathway to Leadership Grant.
CyDex Pharmaceuticals, Inc. today announced that its stockholders have voted to approve an Agreement and Plan of Merger between CyDex and Ligand Pharmaceuticals Incorporated and that closing of the transaction has taken place. CyDex will continue its business operations, based in Lenexa, Kansas, as a wholly owned subsidiary of Ligand.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ryan J Stolworthy, MD Po Box 25535, Salt Lake City, UT 84125 Ph: (866) 898-7136 | Ryan J Stolworthy, MD 1400 N 500 E, Logan, UT 84341 Ph: (435) 716-1000 |
News Archive
A team led by UT Southwestern researchers has identified brain circuitry that plays a key role in the dysfunctional social, repetitive, and inflexible behavioral differences that characterize autism spectrum disorders (ASD).
Trevena Inc., a leader in the discovery of G-protein coupled receptor biased ligands, today announced that its scientists are presenting research data at two scientific conferences. These oral presentations highlight Trevena's research demonstrating that ligand bias at the angiotensin II type I receptor translates into differentiable and beneficial cardiovascular pharmacology in vivo.
The Pancreatic Cancer Action Network and the American Association for Cancer Research have awarded Zeshaan A. Rasheed, M.D., Ph.D., the 2010 Pancreatic Cancer Action Network-AACR Pathway to Leadership Grant.
CyDex Pharmaceuticals, Inc. today announced that its stockholders have voted to approve an Agreement and Plan of Merger between CyDex and Ligand Pharmaceuticals Incorporated and that closing of the transaction has taken place. CyDex will continue its business operations, based in Lenexa, Kansas, as a wholly owned subsidiary of Ligand.
› Verified 7 days ago
Steven G. Nail, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1400 N 500 E, Logan, UT 84341 Phone: 435-716-2250 Fax: 435-716-2250 | |
Douglas P Plowman, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1400 N 500 E, Logan, UT 84341 Phone: 435-716-1000 | |
Mr. Jacob Sanderson, FNP-BC Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1400 N 500 E, Logan, UT 84341 Phone: 435-716-2000 | |
Theral Michael Bishop, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1400 N 500 E, Logan, UT 84341 Phone: 435-716-1000 | |
Rodney L Hammer, Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 179 N Main St Ste 309, Logan, UT 84321 Phone: 435-755-1670 | |
Richard J Ingebretsen, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1400 N 500 E, Logan, UT 84341 Phone: 435-716-1000 |